Top Markets
Coin of the day
Sangui Biotech International, Inc. Sangui Biotech International, Inc.

Sangui Biotech International, Inc.

SGBI
주식 순위 #41118
Sangui Biotech International, Inc., through its subsidiary Sangui BioTech GmbH,... Sangui Biotech International, Inc., through its subsidiary Sangui BioTech GmbH, specializes in creating artificial oxygen carriers derived from hemoglobin. These innovative products are utilized as blood supplements, blood volume replacements, and various related formulations. The company's oxygen carriers are vital for delivering oxygen to humans experiencing acute or chronic oxygen deprivation due to conditions like blocked arteries, anemia, or blood loss, as well as for managing chronic wounds. Their product line also includes nano-formulations designed for skin regeneration, enhancing moisture and elasticity. Furthermore, they provide Chitoskin wound pads to aid in healing and Hemospray, a medical-grade spray specifically formulated for treating persistent wounds. The wound spray products, marketed under the Granulox brand, are primarily distributed in Europe and Mexico, while their cosmetic items are available through an online store. Established in 1995, Sangui Biotech International, Inc. is based in Hamburg, Germany.
주가
$0.0002
마지막 동기화: 2025-07-02
시가총액
$41.98K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
DE
거래 Sangui Biotech International, Inc. (SGBI)

카테고리

Sangui Biotech International, Inc. (SGBI)의 P/B 비율
2026 기준 P/B 비율 TTM: 0
Sangui Biotech International, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 0입니다. 2026년 말 기준 P/B 비율은 0였습니다.
Sangui Biotech International, Inc.의 P/B 비율 기록 (2026 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/B 비율